alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 18-1794V

UNPUBLISHED

ANITA KAPLAN,

 Petitioner,

v.

SECRETARY OF HEALTH AND 

HUMAN SERVICES,

 Respondent.

Chief Special Master Corcoran 

Filed: December 23, 2019

Special Processing Unit (SPU);

Ruling on Entitlement; Concession;

Table Injury; Influenza (Flu) Vaccine;

Guillain-Barre Syndrome (GBS)

Leah VaSahnja Durant, Law Offices of Leah V. Durant, PLLC, Washington, DC, for 

petitioner.

Dhairya Divyakant Jani, U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT1

On November 20, 2018, Anita Kaplan filed a petition for compensation under the 

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,

2

(the 

“Vaccine Act”). Petitioner alleges that she suffered Guillain-Barre Syndrome (“GBS”) as 

a result of an influenza (“flu”) vaccine administered on October 26, 2017. Petition at 1. 

The case was assigned to the Special Processing Unit of the Office of Special Masters.

On December 16, 2019, Respondent filed his Rule 4(c) report in which he

concedes that Petitioner is entitled to compensation in this case. Respondent’s Rule 

4(c) Report at 1. Specifically, Respondent concludes that Petitioner “has satisfied the 

 

1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am 

required to post it on the United States Court of Federal Claims' website in accordance with the EGovernment Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of 

Electronic Government Services). This means the ruling will be available to anyone with access to 

the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to 

redact medical or other information, the disclosure of which would constitute an unwarranted invasion of 

privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such 

material from public access. 

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for 

ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 

300aa (2012).
2

criteria set forth in the Vaccine Injury Table and the Qualifications and Aids to 

Interpretation. 42 C.F.R. §§ 100.3(a)(XIV)(D), 100.3(c)(15).” Id. at 6. 

In view of Respondent’s position and the evidence of record, I find that 

Petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Brian H. Corcoran

Brian H. Corcoran

Chief Special Master
Shirley HIRSHAUER, Petitioner, v. AQ HOLDINGS, LLC, et al.

No. 19-955.

Supreme Court of the United States.

March 30, 2020

Petition for writ of certiorari to the Court of Special Appeals of Maryland denied.
Kazi BOWLES, Petitioner v. FLORIDA DEPARTMENT OF CORRECTIONS, et al.

No. 18-9815

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Mitchell Felix BROOKS, Petitioner, v. UNITED STATES.

No. 18-9206

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
The FIRST PRESBYTERIAN CHURCH U.S.A. OF TULSA, OKLAHOMA, et al., petitioners, v. John DOE.

No. 18-500.

Supreme Court of the United States

Jan. 22, 2019.

Petition for writ of certiorari to the Supreme Court of Oklahoma denied.
Ronelle Lamar OUDEMS, Petitioner, v. UNITED STATES.

No. 19-7713.

Supreme Court of the United States.

March 23, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Jerry Louis HUGHES, Petitioner, v. UNITED STATES.

No. 18-9696

Supreme Court of the United States.

October 07, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
EXHIBIT 21 - Subsidiaries of The Registrant

<TABLE>
<CAPTION>

                                                                  Jurisdiction          Names under which
                                                                      Where               subsidiary does
Name of Subsidiary                                                  Organized                Business
--------------------------------                                  -------------         ------------------
<S>                                                                 <C>                    <C>    
Galion, Inc.                                                        Delaware               Valentec Galion
                                                                                           Valentec Galion, Inc.
                                                                                           Galion, a Division of
                                                                                           Valentec International
                                                                                           Corporation   
                                                                                  
Valentec Systems, Inc.                                              Delaware
ASCI Holdings Germany (DE), Inc.                                    Delaware
ASCI Holdings Mexico (DE), Inc.                                     Delaware
ASCI Holdings UK (DE), Inc.                                         Delaware
ASCI Holdings Czech (DE), Inc.                                      Delaware
ASCI Holdings Asia (DE), Inc.                                       Delaware
Phoenix Airbag Verwaltungs GmbH                                     Germany
Phoenix Airbag GmbH & Co. KG                                        Germany
Automotive Safety Components International S.A. de C.V.             Mexico
Automotive Safety Components International Limited                  United Kingdom
Automotive Safety Components Asia - Pacific Ltd.                    Hong Kong
Automotive Safety Components International, s.r.o.                  Czech Republic
Automotive Safety Components International, Inc.                    Delaware
Valentec International Corporation, LLC                             Delaware               Valentec Wells
Safety Components Fabric Technologies, Inc.                         Delaware
CSSC, Inc. (formerly known as Champion Sales and Service            Arizona
  Company)

</TABLE>
No. 6:23-cv-00553

Chamber of Commerce of the United States of America et al.,

Plaintiffs,

v.

National Labor Relations Board et al.,

Defendants.

ORD ER

In this case, plaintiffs seek permanent injunctive relief from an 

agency final rule, Standard for Determining Joint Employer Status, 

88 Fed. Reg. 73,946 (2023). Pending before the court are the parties’ 

cross-motions for summary judgment (Docs. 10, 34) and defendants’ motion to transfer (Doc. 25). The court held a hearing on those 

motions on February 13, 2024.

The challenged rule currently has an effective date of February 

26, 2024. The court now exercises its authority under 5 U.S.C. § 705 

and stays the effective date of that rule by 14 days. As a result of this 

stay, the new effective date of the rescission of the prior joint-employer rule, 85 Fed. Reg. 11,184 (2020), and implementation of the

new rule is March 11, 2024. An opinion with the court’s reasoning 

will be issued forthwith.

So ordered by the court on February 22, 2024.

J. Campbell Barker

United States District Judge

Case 6:23-cv-00553-JCB Document 43 Filed 02/22/24 Page 1 of 1 PageID #: 908
THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF TEXAS

MARSHALL DIVISION

DISPLAY TECHNOLOGIES, LLC,

Plaintiff,

v.

ROCHE DIABETES CARE, LTD, 

Defendant.

 CIVIL ACTION NO. 2:23-cv-585-JRG

 JURY TRIAL DEMANDED

UNOPPOSED MOTION FOR ENTRY OF DOCKET CONTROL ORDER

Plaintiff files this Unopposed Motion for Entry of this Docket Control Order. The Parties 

have conferred and agreed upon this Docket Control Order. Therefore, Plaintiff respectfully requests 

that the Court approve and enter same, a copy of which is attached hereto.

Dated: June 20, 2024 Respectfully Submitted,

/s/ Randall T. Garteiser

Randall T. Garteiser

 Texas Bar No. 24038912

 rgarteiser@ghiplaw.com

GARTEISER HONEA, PLLC

119 W. Ferguson Street

Tyler, Texas 75702

Telephone: (903) 705-7420

Facsimile: (903) 405-3999

COUNSEL FOR PLAINTIFF

Case 2:23-cv-00585-JRG-RSP Document 32 Filed 06/20/24 Page 1 of 2 PageID #: 897
- 2 -

CERTIFICATE OF CONFERENCE

The undersigned hereby certifies that the parties met and conferred and agreed to the 

Joint Proposed Order. 

/s/ Randall T. Garteiser 

Randall T. Garteiser

CERTIFICATE OF SERVICE

The undersigned hereby certifies that a true and correct copy of the above and foregoing 

document has been served on all counsel of record via the Court’s ECF system. 

/s/ Randall T. Garteiser 

Randall T. Garteiser

Case 2:23-cv-00585-JRG-RSP Document 32 Filed 06/20/24 Page 2 of 2 PageID #: 898
<PAGE>   1
                                                                  EXHIBIT 21.01

                          LIST OF DIRECT SUBSIDIARIES


 1.  Crescent Real Estate Equities, Ltd., a Delaware corporation

 2.  Crescent Real Estate Equities Limited Partnership, a Delaware limited
     partnership

 3.  CRE Management I Corp., a Delaware corporation

 4.  CRE Management II Corp., a Delaware corporation

 5.  CRE Management III Corp., a Delaware corporation

 6.  CRE Management IV Corp., a Delaware corporation

 7.  CRE Management V Corp., a Delaware corporation

 8.  CRE Management VI Corp., a Delaware corporation

 9.  CresCal Properties, Inc., a Delaware corporation

10.  Crescent Real Estate Funding I, L.P., a Delaware limited partnership

11.  Crescent Real Estate Funding II, L.P., a Delaware limited partnership

12.  Crescent Real Estate Funding III, L.P., a Delaware limited partnership

13.  Crescent Real Estate Funding IV, L.P., a Delaware limited partnership

14.  Crescent Real Estate Funding V, L.P., a Delaware limited partnership

15.  Crescent Real Estate Funding VI, L.P., a Delaware limited partnership

16.  CresCal Properties, L.P., a Delaware limited partnership

17.  Waterside Commons Limited Partnership, a Texas limited partnership

18.  Crescent/301, L.L.C., a Delaware limited liability company

19.  G/C Waterside Associates, LLC, a Texas limited liability company
[Federal Register Volume 87, Number 104 (Tuesday, May 31, 2022)]
[Notices]
[Pages 32410-32411]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-11701]


=======================================================================
-----------------------------------------------------------------------

FARM CREDIT ADMINISTRATION


Sunshine Act Meetings

TIME AND DATE: 9 a.m., Thursday, June 9, 2022.

PLACE: You may observe the open portions of this meeting in person at 
1501 Farm Credit Drive, McLean, Virginia 22102-5090, or virtually. If 
you would like to observe, at least 24 hours in advance, visit FCA.gov, 
select

[[Page 32411]]

``Newsroom,'' then select ``Events.'' From there, access the linked 
``Instructions for board meeting visitors'' and complete the described 
registration process.

STATUS: Parts of this meeting will be open to the public. The rest of 
the meeting will be closed to the public.

MATTERS TO BE CONSIDERED: The following matters will be considered:

PORTIONS OPEN TO THE PUBLIC: 
<bullet> Approval of May 12, 2022, Minutes
<bullet> Quarterly Report on Economic Conditions and Farm Credit System 
Condition and Performance
<bullet> Semiannual Report on Office of Examination Operations
<bullet> Cyber Risk Management Proposed Rule

PORTIONS CLOSED TO THE PUBLIC: 
<bullet> Office of Examination Quarterly Report on Supervisory and 
Oversight Activities \1\
---------------------------------------------------------------------------

    \1\ Session Closed-Exempt pursuant to 5 U.S.C. Section 
552b(c)(8) and (9).

CONTACT PERSON FOR MORE INFORMATION: If you need more information or 
assistance for accessibility reasons, or have questions, contact Ashley 
Waldron, Secretary to the Board. Telephone: 703-883-4009. TTY: 703-883-
---------------------------------------------------------------------------
4056.

Ashley Waldron,
Secretary to the Board.
[FR Doc. 2022-11701 Filed 5-26-22; 11:15 am]
BILLING CODE 6705-01-P
Richard HERBERT, petitioner, v. CVS PHARMACY, et al.

No. 17-8963.

Supreme Court of the United States

Oct. 1, 2018.

*98Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
## In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02

- 22

- 00185

- CR

C EDRIC S TOKES

, Appellant

V

.

T HE S TATE OF T EXAS §

§

§

§

§ On Appeal from County Criminal

Court No. 1

of Denton County ( CR

- 2019

- 04275

- A )

February 9 , 2023

Per Curiam Memoran dum Opinion

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that the

appeal should be dismissed. It is ordered that the appeal is dismissed

.

SECOND DISTRICT COURT OF APPEALS

PER CURIAM
Amendment to Employment Agreement



 Exhibit 10.6(i) 

AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN 
 LINDA K. MASSMAN AND CLEARWATER PAPER CORPORATION 
 This Amendment to
Employment Agreement (this “Amendment”) is entered into by and between Linda K. Massman and Clearwater Paper Corporation, effective as of January 1, 2012. 
 RECITALS 
 A. The parties entered into the Employment Agreement effective as of November 1,
2011 (the “Agreement”). 
 B. The parties now wish to enter into this Amendment to modify the target percentages for AIP and LTIP
awards and to clarify that, pursuant to the Agreement, if Ms. Massman is entitled to a pro-rata portion of an equity award, the pro-rata period shall correspond to the applicable performance or vesting period of such equity award. 

NOW THEREFORE the parties agree that the Agreement shall be amended as follows: 

1. In section 4 of the Agreement, “75%” shall be substituted for “70%”. 

2. In section 5 of the Agreement, “150%” shall be substituted for “125%”. 

3. The first full paragraph following subsection 7(b)(iii) of the Agreement shall be amended to read as follows: 

Further, and subject to Section 5(c) of the Severance Program (and any similar or successor section), upon the occurrence of any of the
events specified in Section 5(a) of the Severance Program (and any similar or successor section) prior to a Change of Control (as that term is defined in the Severance Program), you will receive a pro-rated settlement of your performance shares
based on actual performance determined pursuant to the applicable award agreement and pro-rated vesting of your restricted stock units, where applicable, granted under the LTIP. Such performance shares and restricted stock units will be pro-rated
based upon the number of months completed in the applicable performance period or vesting period as of the date of your termination divided by the total number of months in such performance or vesting period. 

[Signature page follows] 







 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Amendment to Employment
Agreement. 
  

			
	CLEARWATER PAPER CORPORATION
		
	By:	 	 /s/ Gordon L. Jones

		 	Gordon L. Jones, CEO
	
	EXECUTIVE:
		
		 	 /s/ Linda K. Massman

		 	Linda K. Massman
Exhibit 11

                                                Oxford Resources Corp.
                                                      and Subsidiaries

                                           Statement of Computation of
                                                  Net Income Per Share

================================================================================

                                            Six Months Ended  Three Months Ended
                                              December 31,       December 31,
                                              1996    1995     1996      1995
--------------------------------------------------------------------------------

(In thousands except per share data)

Net income                                  $11,564  $ 8,575  $ 5,864  $ 4,540
                                            -------  -------  -------  -------
Weighted average common shares
  outstanding                                14,863   13,881   14,887   14,494
Common stock equivalents                        225      232      255      248
                                            -------  -------  -------  -------
Weighted average number of common
  and common equivalent shares outstanding   15,088   14,113   15,142   14,742
                                            =======  =======  =======  =======

Primary earnings per share                  $  0.77  $  0.61  $  0.39  $  0.31
                                            =======  =======  =======  =======
(110 So. 341)

No. 28209.

#### ST. BERNARD TRAPPERS’ ASS’N v. J. Walter MICHEL et al. In re J. Walter MICHEL et al., Applying for Writs of Certiorari and Mandamus.

(Nov. 2, 1926.)

J. R. Perez, F. A. Ahrens, H. G. McMahon and John T. Oonvery, all of New Orleans, Neal A. Armstrong, Jr., of Meraux, and L. H. Perez, of New Orleans, for relators.

W. W. Wall, Clarence Eavrot, James Wilkinson, and O. S. Livaudais, all of New Orleans, for respondents.

O’NIELL, C. J.

This is a proceeding for mandamus to reduce the amount of an appeal bond, fixed by an order of one of the judges of the civil district court. When the judge and the appellee were directed to show cause why the amount of the bond should not be reduced, the appellee consented to the reduction, and the judge ordered it. There is therefore nothing left for decision in this proceeding.

The respondents are discharged from the rule, and this proceeding is dismissed.
Trevon GROSS, Petitioner, v. UNITED STATES.

No. 19-7235

Supreme Court of the United States.

February 24, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
Exhibit 31.1

PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

I, Mark T. Taggatz, certify that:

1.     I have reviewed this annual report on Form 10-KSB of Aquentium, Inc.;

2.     Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statement made, in light of the circumstances under which statements
were made, not misleading with respect to the period covered by this annual
report;

3.     Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the small
business issuer as of, and for, the periods presented in this report.

4.     The small business issuer's other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
small business issuer and have:

       (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;

       (b) Evaluated the effectiveness of the small business issuer's
disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation;
and

       (c) Disclosed in this report any change in the small business issuer's
internal control over financial reporting that occurred during the small
business issuer's most recent fiscal quarter (the small business issuer's
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the small business
issuers's internal control over financial reporting; and

5.     The small business issuer's other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the small business issuer's auditors and the audit
committee of small business issuer's board of directors (or persons performing
the equivalent function):

       (a) All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are reasonably
likely to adversely affect the small business issuer's ability to record,
process, summarize and report financial information; and

       (b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the small business issuer's
internal control over financial reporting.



Date: September 8, 2003       /s/ Mark T. Taggatz
                              ____________________________________
                              Mark T. Taggatz
                              Chief Executive Officer
```
  
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 05/14/13          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      420,043
COMMITMENTS
 111,993  168,420   96,157  184,910  123,341  393,060  387,918   26,983   32,125

CHANGES FROM 05/07/13 (CHANGE IN OPEN INTEREST:     14,951)
  -3,843   -4,466    6,083   11,618    9,970   13,858   11,587    1,093    3,364

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    26.7     40.1     22.9     44.0     29.4     93.6     92.4      6.4      7.6

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      173)
      47       74       71       36       33      132      142
```

----

Updated May 17, 2013
Michael J. WARNER, II, Petitioner, v. MAINE.

No. 19-6816

Supreme Court of the United States.

Feb. 24, 2020

Petition for writ of certiorari to the Supreme Judicial Court of Maine denied.
John L. WILLIAMS, Petitioner, v. JACKSON COUNTY, MISSOURI.

No. 19-7344.

Supreme Court of the United States.

March 23, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Tommy Earl BOONE, Jr., petitioner, v. TEXAS.

No. 18-8200.

Supreme Court of the United States

June 24, 2019.

Petition for rehearing denied.